Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
235.6 CHF | +0.60% | -1.83% | -9.87% |
Apr. 29 | Swiss Equities Close in Red Amid Inflation Spotlight | MT |
Apr. 29 | Roche Holding AG: slimming down |
Sales 2024 * | 60.04B 66.32B | Sales 2025 * | 63.82B 70.49B | Capitalization | 175B 194B |
---|---|---|---|---|---|
Net income 2024 * | 13.46B 14.87B | Net income 2025 * | 14.87B 16.42B | EV / Sales 2024 * | 3.16 x |
Net Debt 2024 * | 14.25B 15.74B | Net Debt 2025 * | 8.18B 9.04B | EV / Sales 2025 * | 2.87 x |
P/E ratio 2024 * |
12.7
x | P/E ratio 2025 * |
11.6
x | Employees | 103,605 |
Yield 2024 * |
4.47% | Yield 2025 * |
4.63% | Free-Float | 88.91% |
Latest transcript on Roche Holding AG
1 day | +0.60% | ||
1 week | -1.83% | ||
Current month | -2.16% | ||
1 month | -1.42% | ||
3 months | -5.00% | ||
6 months | -6.80% | ||
Current year | -9.87% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 02-12-31 | |
Severin Schwan
CHM | Chairman | 57 | 07-12-31 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 11-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 15-03-02 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 95-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.06% | 2 M€ | -.--% | - | |
2.06% | 2 M€ | +9.19% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 235.6 | +0.60% | 25,523 |
24-05-02 | 234.2 | -2.74% | 45,876 |
24-04-30 | 240.8 | -0.17% | 33,510 |
24-04-29 | 241.2 | +0.50% | 28,407 |
24-04-26 | 240 | +1.35% | 43,749 |
Delayed Quote Swiss Exchange, May 03, 2024 at 11:30 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-3.40% | 157B | |
+8.08% | 167B |
- Stock Market
- Equities
- ROG Stock
- RO Stock